"Scientists recently published research indicating that they induced mouse skin cells to be "reprogrammed" back into an embryonic state. Such advances tantalize researchers, social conservatives and stem cell advocates alike, but raise many questions. Can such cells be used in research as screening tools? Will the results of this research really be applicable one day to humans, giving us the era of truly personalized medicine? What will be the pros and cons of therapies based on skin cells vs. adult and embryonic stem cells? Join business leaders, scientists and policy experts to discuss the science behind the headlines as well as possible applications and business and policy implications behind this potentially
paradigm-shifting advancement."

Objective1:Analyze recent research advances demonstrating the reprogramming of somatic cells to an embryonic state.

Objective2:Present the commercial applications of such research from a tools and a therapeutics perspective.

Objective3:Discuss the policy implications of such research.